Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

St. Jude Medical’s HeartMate 3 LVAS obtains CE mark approval

St. Jude Medical has obtained CE mark approval for its HeartMate 3 left ventricular assist system (LVAS), allowing for the product's marketing in the European Union (EU) region.

HM

The new system is a cardiac support option for advanced heart failure patients who are expected to have a transplantation or are under myocardial recovery.

Claimed to be the first commercially approved centrifugal-flow left ventricular assist device (LVAD), the system uses Full MagLev technology to suspend the device’s rotor through magnetic forces.

HeartMate 3 system’s centrifugal blood pump is implanted directly onto a patient’s native heart, to pump up to 10l of blood per minute.

The approval was granted based on the data of HeartMate 3 CE mark clinical trial that reached its primary endpoint and showed a 92% six-month survival rate.

Completed in November 2014, the study enrolled 50 patients, including both bridge-to-transplant and destination therapy patients, at 10 hospitals in six countries outside the US.

St. Jude Medical group president Dr Eric Fain said: "We are pleased to announce CE Mark approval of the next-generation HeartMate 3 system, which has been proven through the HeartMate 3 CE Mark study to show high survival rates, material improvements in functional status, and very low adverse event rates highlighted by zero pump thrombosis events."

The firm is planning for a limited market release of the system across Europe, and will introduce in additional markets throughout next year.

Last week, St. Jude Medical completed the $3.3bn acquisition of Thoratec, which develops mechanical circulatory support (MCS) technology to treat advanced heart failure.

St. Jude acquired HeartMate II LVAD, CentriMag and PediMag/PediVAS, HeartMate 3 and HeartMate PH from Thoratec.


Image: St. Jude’s HeartMate 3 left ventricular assist system. Photo: courtesy of Business Wire.